Evaluation on antiviral activity of a novel arctigenin derivative against multiple rhabdoviruses in aquaculture

Yu-Feng Shen,Yi-Hang Liu,Bo-Yang Li,Tian-Qiang Liu,Gao-Xue Wang
DOI: https://doi.org/10.1016/j.virusres.2020.198019
IF: 6.286
2020-08-01
Virus Research
Abstract:<p>Rhabdoviruses cause devastating diseases in aquaculture, resulting in enormous economic losses. Our previous studies indicated that imidazole arctigenin derivatives possessed antiviral activities against aquatic rhabdoviruses. Based on the data of structure-activity relationship, a new imidazole arctigenin derivative, 4-(8-(2-bromoimidazole)octyloxy)-arctigenin (BOA), was designed and synthesized. And its antiviral activities against aquatic rhabdoviruses (SVCV, IHNV and MSRV) were evaluated <em>in vitro</em>. By comparing inhibitory concentration at half-maximal activity (IC <sub>50</sub>), we found that BOA (IC<sub>50</sub> = 1.11 μM) possessed a higher anti-IHNV activity than the antiviral imidazole arctigenin derivatives which were found in our previous study. Besides, BOA could cause profound inhibition of SVCV and MSRV replication. By the reduction assays on cytopathic effect, BOA exhibited a protective effect on two host cell lines. As a typical rhabdovirus, SVCV was chosen as a model to illuminate the anti-rhabdovirus mechanism of BOA. BOA was discovered to not impact directly on viral particles or interfere with SVCV adsorption. And it worked within the 2-6 h of the early phase of virus replication. In addition, after repression of cell cycle S phase and recovery of caspase-3/8/9 activities activated by SVCV, BOA inhibited SVCV-induced apoptosis and then reduced the release of viral particles at the late stage of virus replication. Altogether, BOA was expected to be a highly efficient antiviral agent against multiple rhabdoviruses in the field of aquaculture.</p>
virology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the serious diseases caused by Rhabdoviruses in aquaculture, which have led to huge economic losses. Specifically, the research aims to evaluate the antiviral activity of a new lignan derivative (4 - (8 - (2 - bromoimidazole) octyloxy) - lignan, abbreviated as BOA) against various aquatic rhabdoviruses such as Spring Viremia of Carp Virus (SVCV), Infectious Hematopoietic Necrosis Virus (IHNV) and Micropterus salmoides Rhabdovirus (MSRV). Through in - vitro experiments, the researchers hope to determine whether BOA can effectively inhibit the replication of these viruses and explore its antiviral mechanism. The key points of the paper include: 1. **Design and Synthesis**: Based on the structure - activity relationship data, a new imidazole lignan derivative BOA was designed and synthesized. 2. **Antiviral Activity Evaluation**: The antiviral activity of BOA against SVCV, IHNV and MSRV was evaluated by comparing the half - maximal inhibitory concentration (IC50). 3. **Cell - protection Effect**: The protective effect of BOA in host cells was verified by the cytopathic effect (CPE) reduction test. 4. **Antiviral Mechanism Research**: Using SVCV as a model, the antiviral mechanism of BOA was studied, including the influence on virus particles, the interference with virus adsorption, the role in the early stage of virus replication and the inhibition of apoptosis. In conclusion, the goal of this research is to develop highly effective broad - spectrum antiviral agents to deal with the high mortality and huge economic losses caused by rhabdoviruses in aquaculture.